| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 55268-74-1 | 吡喹酮; 2-環(huán)己基甲�；�-1,2,3,6,7,11b-六氫-4H-吡嗪并[2,1-a]異喹啉-4-酮 | Praziquantel; 2-Cyclohexyl-carbonyl-1,3,4,6,7,11b-hexahydro-2H-pyrazine(2,1-a)isoquinoline-4-one |  | C19H24N2O2 | 詳情 | 供應商 |
| 38917-80-5 | Acetamide,2-(diethylamino)-N-[3-(phenylmethoxy)phenyl]-; Acetanilide,3'-(benzyloxy)-2-diethylamino- (6CI); 2-(Diethylamino)-3'-(benzyloxy)acetanilide |  | C19H24N2O2 | 詳情 | 供應商 | |
| 1164-22-3 | Acetamide,2-[(4-ethoxyphenyl)amino]-N-(1-methyl-2-phenylethyl)-; Acetamide,N-(a-methylphenethyl)-2-p-phenetidino-(8CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 1163-54-8 | Benzeneacetamide, a-[(4-ethoxyphenyl)amino]-N-propyl-; Acetamide,2-p-phenetidino-2-phenyl-N-propyl- (8CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 6376-26-7 | Benzamide,2-[2-(diethylamino)ethoxy]-N-phenyl-; Benzanilide,2-[2-(diethylamino)ethoxy]- (7CI,8CI); 2-[2-(Diethylamino)ethoxy]benzanilide; Ajurac; Biospal; M 811; Salverine |  | C19H24N2O2 | 詳情 | 供應商 | |
| 102008-47-9 | Benzeneacetamide,N-[5-(4-aminophenoxy)pentyl]-; Acetamide,N-[5-(p-aminophenoxy)pentyl]-2-phenyl- (6CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 74249-07-3 | Benzamide,4-[3-[(2-hydroxy-2-phenylethyl)amino]butyl]-, [R-(R*,S*)]- (9CI); 4-(3-((2-hydroxy-2-phenethyl)amino)butyl)benzamide |  | C19H24N2O2 | 詳情 | 供應商 | |
| 6443-50-1 | Benzeneethanimidamide,N-[2-(3-methoxyphenoxy)propyl]-3-methyl-; Acetamidine,N-[2-(m-methoxyphenoxy)propyl]-2-m-tolyl- (7CI,8CI); Xylamidine; Xylamidine(5-hydroxytryptamine antagonist) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 6393-84-6 | Benzamide,4-[2-(diethylamino)ethoxy]-N-phenyl-; Benzanilide,4-[2-(diethylamino)ethoxy]- (7CI,8CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 15585-88-3 | Carbamic acid,diphenyl-, 2-(diethylamino)ethyl ester (6CI,7CI,8CI,9CI); Dicarfen; SD 25 |  | C19H24N2O2 | 詳情 | 供應商 | |
| 5962-19-6 | Cinchonan-6',9-diol,10,11-dihydro-, (8a,9R)-; Hydrocupreine(6CI,8CI); 10,11-Dihydrocupreine; 6'-Hydroxydihydrocinchonidine; O6'-Demethylhydroquinine |  | C19H24N2O2 | 詳情 | 供應商 | |
| 23943-35-3 | Curan-3-ol,17,19-epoxy-, (19S)- (9CI); Isostrychnosplendine(8CI); 7aH-7,9-Methanopyrano[3,4-a]pyrrolo[2,3-d]carbazole, curan-3-ol deriv.; 19-Isostrychnosplendine |  | C19H24N2O2 | 詳情 | 供應商 | |
| 100181-51-9 | Ergoline-1-methanol,6,8-dimethyl-, acetate (ester), (8b)- (9CI); Festuclavine,1-(hydroxymethyl)-, acetate (6CI); Indolo[4,3-fg]quinoline, ergoline-1-methanolderiv.; 1-Acetoxymethylfestuclavine |  | C19H24N2O2 | 詳情 | 供應商 | |
| 28008-74-4 | Indolo[2,3-a]quinolizine-2-ethanol,b-ethenyl-1,2,3,4,6,7,12,12b-octahydro-9-hydroxy-,(bR,2S,12bR)-; 18,20-Seco-E-nor-3b,15b-yohimban-16b-methanol, 17,18-didehydro-10-hydroxy- (8CI); Indolo[2,3-a]quinolizine-2-ethanol, b-ethenyl-1,2,3,4,6,7,12,12b-octahydro-9-hydroxy-,[2S-[2a(S*),12bb]]-; 3-Epihunterburnine |  | C19H24N2O2 | 詳情 | 供應商 | |
| 25795-34-0 | Indolo[2,3-a]quinolizine-1-aceticacid, 1-ethyl-1,2,3,4,6,7,12,12b-octahydro-, (1R,12bR)- (9CI); 1,14-Secoeburnamenin-14(15H)-oicacid; Eburnamoninic acid (6CI); 1,14-Secoeburnamin-14-oic acid; Indolo[2,3-a]quinolizine-1-acetic acid, 1-ethyl-1,2,3,4,6,7,12,12b-octahydro-,(1R-trans)- |  | C19H24N2O2 | 詳情 | 供應商 | |
| 63978-39-2 | Piperazine,1-[(3,4-dimethoxyphenyl)methyl]-4-phenyl-; Piperazine,1-phenyl-4-veratryl- (7CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 63978-38-1 | Piperazine,1-[(2,5-dimethoxyphenyl)methyl]-4-phenyl-; Piperazine,1-(2,5-dimethoxybenzyl)-4-phenyl- (7CI) |  | C19H24N2O2 | 詳情 | 供應商 | |
| 106609-35-2 | 1-Piperazineethanol,4-[(4-hydroxy[1,1'-biphenyl]-3-yl)methyl]-; 4-(2-Hydroxy-5-phenylbenzyl)-1-piperazineethanol |  | C19H24N2O2 | 詳情 | 供應商 | |
| 28380-23-6 | Vobasan-10,17-diol,4-demethyl-, (16R)- (9CI); 3,4-Secosarpagine(8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-10,17-diol deriv.; (16R)-N-Demethylvobasan-10,17-diol; 3,4-Secosarpagan-10,17-diol |  | C19H24N2O2 | 詳情 | 供應商 | |
| 107615-76-9 | 12H-Dibenzo[d,g][1,3,6]dioxazocine-12-propanamine,N,N,b-trimethyl-; EGYT2509 |  | C19H24N2O2 | 詳情 | 供應商 | |